Comparative safety and tolerability of anti-VEGF therapy in age-related macular degeneration
about
Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab.HDAC inhibition in the cpfl1 mouse protects degenerating cone photoreceptors in vivo.Effects of intravitreally injected Fc fragment on rat eyes.Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells.
P2860
Comparative safety and tolerability of anti-VEGF therapy in age-related macular degeneration
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Comparative safety and tolerab ...... e-related macular degeneration
@ast
Comparative safety and tolerab ...... e-related macular degeneration
@en
Comparative safety and tolerab ...... e-related macular degeneration
@nl
type
label
Comparative safety and tolerab ...... e-related macular degeneration
@ast
Comparative safety and tolerab ...... e-related macular degeneration
@en
Comparative safety and tolerab ...... e-related macular degeneration
@nl
prefLabel
Comparative safety and tolerab ...... e-related macular degeneration
@ast
Comparative safety and tolerab ...... e-related macular degeneration
@en
Comparative safety and tolerab ...... e-related macular degeneration
@nl
P2093
P2860
P1433
P1476
Comparative safety and tolerab ...... e-related macular degeneration
@en
P2093
Carley Tanchon
Justis P. Ehlers
Yasha S. Modi
P2860
P2888
P304
P356
10.1007/S40264-015-0273-0
P407
P577
2015-03-01T00:00:00Z
P6179
1036269062